Galapagos
Biotechnology ResearchView the employees at
Galapagos-
kristof lesneuck Clinical Study Leader Phase 2-3 at Galapagos
-
Antwerp Metropolitan Area
-
Rising Star
Coraline RUIZ Technicienne in-vivo-
Épinay-sous-Sénart, Île-de-France, France
-
Rising Star
Armido Camarda Territory Manager presso Galapagos-
Palermo, Sicily, Italy
-
Rising Star
Potherat Stephanie Attachee scientifique hospitaliere chez Galapagos en Champagne Lorraine-
Top 10%
Kasper Van Waes Freelance program and project manager-
Leuven, Flemish Region, Belgium
-
Top 10%
Overview
We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.
-